Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery: design and characterization

Levofloxacin (LV) is a hydrophilic broad-spectrum antibiotic commonly used in pulmonary treatment against recurrent infections of Pseudomonas aeruginosa, and particularly in cystic fibrosis (CF) disease. In order to study feasible carriers for LV, solid lipid nanoparticles (SLN) of myristyl myristat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Islan, Germán Abel, Cortez Tornello, Pablo Roberto, Abraham, Gustavo Abel, Duran, Nelson, Castro, Guillermo Raúl
Formato: Articulo Preprint
Lenguaje:Inglés
Publicado: 2016
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/102264
https://ri.conicet.gov.ar/11336/40036
Aporte de:
id I19-R120-10915-102264
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Química
Cystic fibrosis
DNase
Levofloxacin
Nanostructured lipid carriers
Pulmonary delivery
Solid lipid nanoparticles
spellingShingle Química
Cystic fibrosis
DNase
Levofloxacin
Nanostructured lipid carriers
Pulmonary delivery
Solid lipid nanoparticles
Islan, Germán Abel
Cortez Tornello, Pablo Roberto
Abraham, Gustavo Abel
Duran, Nelson
Castro, Guillermo Raúl
Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery: design and characterization
topic_facet Química
Cystic fibrosis
DNase
Levofloxacin
Nanostructured lipid carriers
Pulmonary delivery
Solid lipid nanoparticles
description Levofloxacin (LV) is a hydrophilic broad-spectrum antibiotic commonly used in pulmonary treatment against recurrent infections of Pseudomonas aeruginosa, and particularly in cystic fibrosis (CF) disease. In order to study feasible carriers for LV, solid lipid nanoparticles (SLN) of myristyl myristate were prepared by the ultrasonication method in the presence of Pluronic®F68 under different experimental conditions and characterized by dynamic light scattering, optical, transmission and scanning electron microscopy for size and morphology. Alternatively, nanostructured lipid carriers (NLCs) were developed to improve LV encapsulation and storage. SLN showed 20.1 ± 1.4% LV encapsulation efficiency, while the NLCs encapsulated 55.9 ± 1.6% LV. NLC formulation exhibited a more controlled release profile than SLN formulation, but both showed a biphasic drug release pattern with burst release at the first 5 h and prolonged release afterwards, demonstrated by in vitro tests. The hydrodynamic average diameter and zeta potential of NLC were 182.6 ± 3.2 nm and -10.2 ± 0.2 mV, respectively, and were stable for at least 3 months. Additionally, DNase type I was incorporated into the formulations as a "smart" component, since the enzyme could help to decrease the viscoelasticity found in the lungs of CF patients and improves the antibiotic diffusion. FTIR, XRD, DSC, TGA and nitrogen adsorption isotherms of the nanoparticles indicate the presence of the loads in a noncrystalline state. The developed formulation showed an active antimicrobial activity against P. aeruginosa and even against other opportunistic pathogens such as Staphylococcus aureus. The presence of LV-loaded NLCs reduced the formation of a bacterial biofilm, which highlighted the significance of the nanodevice as a new alternative for CF treatment.
format Articulo
Preprint
author Islan, Germán Abel
Cortez Tornello, Pablo Roberto
Abraham, Gustavo Abel
Duran, Nelson
Castro, Guillermo Raúl
author_facet Islan, Germán Abel
Cortez Tornello, Pablo Roberto
Abraham, Gustavo Abel
Duran, Nelson
Castro, Guillermo Raúl
author_sort Islan, Germán Abel
title Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery: design and characterization
title_short Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery: design and characterization
title_full Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery: design and characterization
title_fullStr Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery: design and characterization
title_full_unstemmed Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery: design and characterization
title_sort smart lipid nanoparticles containing levofloxacin and dnase for lung delivery: design and characterization
publishDate 2016
url http://sedici.unlp.edu.ar/handle/10915/102264
https://ri.conicet.gov.ar/11336/40036
work_keys_str_mv AT islangermanabel smartlipidnanoparticlescontaininglevofloxacinanddnaseforlungdeliverydesignandcharacterization
AT corteztornellopabloroberto smartlipidnanoparticlescontaininglevofloxacinanddnaseforlungdeliverydesignandcharacterization
AT abrahamgustavoabel smartlipidnanoparticlescontaininglevofloxacinanddnaseforlungdeliverydesignandcharacterization
AT durannelson smartlipidnanoparticlescontaininglevofloxacinanddnaseforlungdeliverydesignandcharacterization
AT castroguillermoraul smartlipidnanoparticlescontaininglevofloxacinanddnaseforlungdeliverydesignandcharacterization
bdutipo_str Repositorios
_version_ 1764820440918786048